The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome.

Cardiovascular Diabetology
Arie SteinvilOri Rogowski

Abstract

Metabolic syndrome (MetS) is frequently characterized by elevated liver enzymes, including gamma-glutamyl transferase (GGT) and alanine aminotransferase (ALT). Our objective was to evaluate the range of prevalence of MetS in apparently healthy individuals whose liver enzyme concentrations were all within-normal-range. We have performed a cross sectional analysis on participants of the Tel-Aviv medical center inflammation survey (TAMCIS) recruited between the years 2003-2009. Analyzed were a cohort of 6,561 men and 3,389 women. The prevalence of MetS increased significantly from the first quintile to the fifth for both GGT and ALT, all the five quintiles being in the normal range. Logistic regression analysis for the presence of MetS showed crude odds ratios of 2.7 and 2.4 between the first and fourth quintiles and 3.6 and 3.2 for the fifth quintile in men and women respectively for ALT. For GGT the respective odds being 3.6 and 3.2 for the fourth quintile and 3.9 and 3.4 for the fifth quintile in men and women, respectively. A relatively high prevalence of MetS was noted in a cohort of apparently healthy individuals with liver enzyme concentrations within-normal-limits. Practical consequences include the need to follow up these...Continue Reading

References

Feb 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M E AndersonA Meister
Aug 6, 2000·Stroke; a Journal of Cerebral Circulation·P JousilahtiJ Tuomilehto
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Dec 4, 2002·JAMA : the Journal of the American Medical Association·Hanna-Maaria LakkaJukka T Salonen
Jul 2, 2003·Cardiovascular Diabetology·Alexander TenenbaumMichael Motro
Dec 28, 2004·The American Journal of Cardiology·Ori RogowskiShlomo Berliner
Jun 29, 2005·Diabetes Care·Monica NannipieriUNKNOWN Mexico City diabetes study
Aug 3, 2005·Circulation·Jacqueline M DekkerRobert J Heine
Sep 28, 2005·Circulation·Elfriede RuttmannUNKNOWN Vorarlberg Health Monitoring and Promotion Program Study Group
Aug 8, 2006·Medical Hypotheses·Okan TurgutM Birhan Yilmaz
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mattias EkstedtStergios Kechagias
Nov 11, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Douglas S LeeRamachandran S Vasan
May 29, 2007·Journal of the American College of Cardiology·Jørgen JeppesenSten Madsbad
Jun 28, 2007·The Journal of Clinical Endocrinology and Metabolism·Anna KotronenHannele Yki-Järvinen
Dec 20, 2007·Plastic and Reconstructive Surgery·Henry A MentzLaura A Miniel
Mar 5, 2008·Journal of Thrombosis and Haemostasis : JTH·K KainE M Scott
Mar 22, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Jean-Pierre DesprésPaul Poirier
Oct 22, 2008·The American Journal of Cardiology·Arie SteinvilOri Rogowski
Oct 16, 2009·Cardiovascular Diabetology·Ori RogowskiItzhak Shapira

❮ Previous
Next ❯

Citations

Mar 23, 2011·Clinical and Experimental Pharmacology & Physiology·Ming-Feng XiaXin Gao
Jan 29, 2011·Cardiovascular Diabetology·Alexander Tenenbaum, Enrique Z Fisman
May 30, 2015·The Canadian Journal of Cardiology·Chiara CaselliUNKNOWN EVINCI Study Investigators
Aug 8, 2018·International Journal of Environmental Research and Public Health·Hae Ran Kim, Mi Ah Han
Oct 10, 2015·Oncotarget·Lu ZhangHongyan Xiong

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.